251 related articles for article (PubMed ID: 26033777)
1. Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012.
Baldur-Felskov B; Munk C; Nielsen TS; Dehlendorff C; Kirschner B; Junge J; Kjaer SK
Cancer Causes Control; 2015 Aug; 26(8):1105-16. PubMed ID: 26033777
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi-cohort vaccination against human papillomavirus infection.
Ring LL; Munk C; Galanakis M; Tota JE; Thomsen LT; Kjaer SK
Int J Cancer; 2023 Apr; 152(7):1320-1327. PubMed ID: 36250312
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.
Baldur-Felskov B; Dehlendorff C; Junge J; Munk C; Kjaer SK
Cancer Causes Control; 2014 Jul; 25(7):915-22. PubMed ID: 24797870
[TBL] [Abstract][Full Text] [Related]
4. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
van der Horst J; Siebers AG; Bulten J; Massuger LF; de Kok IM
Cancer Med; 2017 Feb; 6(2):416-423. PubMed ID: 28102052
[TBL] [Abstract][Full Text] [Related]
5. Risk of head-and-neck cancer following a diagnosis of severe cervical intraepithelial neoplasia: a nationwide population-based cohort study in Denmark.
Svahn MF; Munk C; Jensen SM; von Buchwald C; Frederiksen K; Kjaer SK
Gynecol Oncol; 2016 Jul; 142(1):128-132. PubMed ID: 27106016
[TBL] [Abstract][Full Text] [Related]
6. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
[TBL] [Abstract][Full Text] [Related]
7. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
[TBL] [Abstract][Full Text] [Related]
8. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer incidence in Denmark over six decades (1943-2002).
Kyndi M; Frederiksen K; Krüger Kjaer S
Acta Obstet Gynecol Scand; 2006; 85(1):106-11. PubMed ID: 16521689
[TBL] [Abstract][Full Text] [Related]
11. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
12. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.
Hinkula M; Pukkala E; Kyyrönen P; Laukkanen P; Koskela P; Paavonen J; Lehtinen M; Kauppila A
Br J Cancer; 2004 Mar; 90(5):1025-9. PubMed ID: 14997202
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
15. High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study.
Thamsborg LH; Napolitano G; Larsen LG; Lynge E
Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1290-1296. PubMed ID: 32754966
[TBL] [Abstract][Full Text] [Related]
16. Dose-related Effectiveness of Quadrivalent Human Papillomavirus Vaccine Against Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
Verdoodt F; Dehlendorff C; Kjaer SK
Clin Infect Dis; 2020 Feb; 70(4):608-614. PubMed ID: 30892587
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
[TBL] [Abstract][Full Text] [Related]
18. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study.
Mix JM; Van Dyne EA; Saraiya M; Hallowell BD; Thomas CC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):30-37. PubMed ID: 33082207
[TBL] [Abstract][Full Text] [Related]
19. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
